Drug Type Monoclonal antibody |
Synonyms Anti-PNAG-monoclonal-antibody, Anti-poly-N-acetyl-glucosamine-monoclonal-antibody + [3] |
Mechanism Poly-N-acetyl glucosamine inhibitors, Surface antigens inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Start Date29 Nov 2017 |
Sponsor / Collaborator |
Start Date01 Oct 2011 |
Sponsor / Collaborator |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Gonorrhea | Phase 3 | US | 29 Nov 2017 | |
Urethral Infection | Phase 3 | US | 29 Nov 2017 | |
Infectious Diseases | Phase 3 | US | 01 Oct 2011 |
Study | Phase | Population | Analyzed Enrollment | Group | Results | Evaluation | Publication Date |
---|
No Data |